Ronald Blue Trust, Inc. Bio Techne Corp Transaction History

Ronald Blue Trust, Inc.

$7.68 Billion
Q1 2025

A detailed history of Ronald Blue Trust, Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 330 shares of TECH stock, worth $15,942. This represents 0.0% of its overall portfolio holdings.

Number of Shares

330

Previous 162 103.7%

Holding current value

$15,942

Previous $11,000 72.73%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 21, 2025	BUY	$58.47 - $78.75 $9,822 - $13,230	168 Added 103.7%	330 $19,000
Q4 2024 Jan 30, 2025	SELL	$66.37 - $78.17 $74,334 - $87,550	-1,120 Reduced 87.36%	162 $11,000
Q4 2024 Jan 22, 2025	SELL	$66.37 - $78.17 $3,318 - $3,908	-50 Reduced 3.75%	1,282 $92,000
Q3 2024 Oct 17, 2024	SELL	$70.96 - $82.35 $111,903 - $129,865	-1,577 Reduced 54.21%	1,332 $106,000
Q2 2024 Jul 18, 2024	BUY	$62.12 - $84.15 $173,873 - $235,535	2,799 Added 2544.55%	2,909 $208,000
Q1 2024 May 01, 2024	BUY	$65.98 - $77.09 $1,451 - $1,695	22 Added 25.0%	110 $7,000
Q4 2023 Jan 18, 2024	BUY	$52.83 - $78.22 $1,849 - $2,737	35 Added 66.04%	88 $6,000
Q3 2023 Oct 11, 2023	BUY	$67.52 - $89.42 $2,565 - $3,397	38 Added 253.33%	53 $4,000
Q2 2023 Jul 14, 2023	SELL	$73.76 - $85.98 $7,671 - $8,941	-104 Reduced 87.39%	15 $1,000
Q1 2023 Apr 17, 2023	BUY	$71.62 - $86.62 $6,374 - $7,709	89 Added 296.67%	119 $10,000
Q4 2022 Jan 17, 2023	BUY	$80.67 - $352.29 $484 - $2,113	6 Added 25.0%	30 $9,000
Q3 2022 Oct 21, 2022	BUY	$282.54 - $391.85 $4,238 - $5,877	15 Added 166.67%	24 $8,000
Q2 2022 Aug 09, 2022	BUY	$322.67 - $449.65 $2,904 - $4,046	9 New	9 $4,000

Others Institutions Holding TECH

# of Institutions

627

Shares Held

160M

Call Options Held

90K

Put Options Held

14.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $1.89B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.

Account

Ronald Blue Trust, Inc. Bio Techne Corp Transaction History